Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.1800
-0.1088 (-37.67%)
Feb 26, 2026, 1:49 PM EST
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $593.03 thousand as of February 26, 2026. Its market cap has decreased by -85.23% in one year.
Market Cap
593.03K
Enterprise Value
-4.37M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 593.03K, a decrease of -97.85%. That is a compound annual growth rate of -35.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 593.03K | -72.61% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 1.20M |
| Evofem Biosciences | 1.16M |
| International Stem Cell | 1.08M |
| Halberd | 1.08M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 982.64K |
| Protagenic Therapeutics | 867.55K |
| EV Biologics | 840.53K |